SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper ...
The Caris Lookback Program identified 13,293 patients potentially eligible for newly approved targeted therapies across 10 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results